Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” at StockNews.com
StockNews.com upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) to a sell rating in a research report released on Saturday morning. A number of other research analysts also recently issued reports on MDGL. Citigroup reduced their price objective on Madrigal Pharmaceuticals from $382.00 to $371.00 and set a buy rating for the company in […]
More Stories
Tribe Price Reaches $0.42 on Exchanges (TRIBE)
Tribe (TRIBE) traded 7.5% lower against the US dollar during the 24-hour period ending at 13:00 PM E.T. on October...
Shira Ridge Wealth Management Sells 1,985 Shares of iShares Global Clean Energy ETF (NASDAQ:ICLN)
Shira Ridge Wealth Management trimmed its stake in shares of iShares Global Clean Energy ETF (NASDAQ:ICLN – Free Report) by...
JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST) Stock Position Boosted by Crestmont Private Wealth LLC
Crestmont Private Wealth LLC increased its holdings in shares of JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST – Free Report) by 4.0%...
BlackRock Health Sciences Trust (BME) To Go Ex-Dividend on October 15th
BlackRock Health Sciences Trust (NYSE:BME – Get Free Report) declared a monthly dividend on Thursday, September 12th, NASDAQ reports. Stockholders...
DeepOnion Price Reaches $0.0500 on Top Exchanges (ONION)
DeepOnion (ONION) traded down 1.2% against the U.S. dollar during the 24-hour period ending at 13:00 PM ET on October...
Crestmont Private Wealth LLC Acquires Shares of 1,009 Old Dominion Freight Line, Inc. (NASDAQ:ODFL)
Crestmont Private Wealth LLC bought a new position in Old Dominion Freight Line, Inc. (NASDAQ:ODFL – Free Report) during the...